852333-59-6Relevant academic research and scientific papers
INHIBITORS OF RAF KINASES
-
Paragraph 00151-00153; 00162-00164, (2022/04/03)
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
SUBSTITUTED PYRIDINE DERIVATIVES
-
Page/Page column 39, (2008/06/13)
The present invention relates to pyridine derivatives of the general formula (I) and their use as openers of the KCNQ family potassium ion channels for the treatment of CNS disorders.
PYRIDINE COMPOUNDS
-
Page/Page column 85-86, (2008/06/13)
This invention features compounds of formula (I): pharmaceutical compositions of the compounds, and methods of using the compounds for the treatment of, inter alia, IL-12-related diseases and disorders.
